ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Renal Transplantation with Final Allocation Based on the Virtual Crossmatch: Outcomes at 5 Years

C. Johnson, Y. Zhu, M. Zhang, B. Shames, A. Roza, D. Cronin, S. Hariharan, J. Schiller, T. Ellis

Departments of Surgery, Medicine and Biostatistics, Medical College of Wisconsin, Milwaukee, WI
The Blood Center of Wisconsin, Milwaukee, WI

Meeting: 2013 American Transplant Congress

Abstract number: 171

Related Abstracts
  • Outcomes Following Positive Crossmatch Renal Transplantation Despite Failure To Convert to Negative Flow Crossmatch after Desensitization
  • Flow Crossmatching for Renal Transplantation in the Virtual Crossmatch Era: Fifty Shades of Grey

Background: Use of the virtual crossmatch (VC) has been shown to increase the efficiency of identifying compatible renal transplant recipients from a given donor. However the flow crossmatch (FC) has remained the generally accepted method for assessing final compatibility. Since 2005 we have followed a protocol at our center whereby the final allocation decision is based on the VC, not the FC. Here we report the 5 year results using this protocol, with emphasis on outcomes in FC+ (T or B cell) compared to FC- recipients.

Methods: Between Jan. 2005 and Jan. 2010, 508 consecutive kidney-only (VC-)transplants were performed. VC were determined using solid phase assays for HLA antibodies. Primary outcomes are patient, graft survival and incidence of acute rejection within one year (AR<1). Survival data were reconciled with data submitted for SRTR analysis. Outcomes for FC+ (n=56) and FC- (n=452) recipients were adjusted (using a stratified Cox regression model) for co-variates such as age, gender, race, diabetes, donor type (LD vs DD), duration of dialysis, retransplant and PRA.

Results: Mean follow up is 5.1 years. FC+ recipients (n=56)were significantly different from FC- recipients (n=456) for the following risk factors: LD (23% vs 39%, p=0.03), duration of dialysis (40.7 mo vs 33 mo, p=0.001), retransplant (16% vs 7.3%, p=0.04), PRA>0 (64% vs18%, p=0.001), PRA> 80% (21% vs 3.5%, p=0.001). Risk adjusted 5 year graft survivals are 85 and 86% (figure1). AR<1 occurred in 13% FC+ and 12% FC-. Significant risk factors for graft loss include DD (RR 2.7, p<0.001) and diabetes (RR 2.0, p=0.003) but not crossmatch status (RR 0.95). Subset analysis limited to sensitized patients only (n= 36 FC+ and n=82 FC-) shows 3 year actual graft survivals of 87% and 92% respectively(p=0.4).

Conclusion: A protocol which utilizes the VC to determine final compatibility can yield good intermediate term results for renal transplantation. Additional time and patient accrual are needed to better assess long term outcomes using this strategy.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Johnson C, Zhu Y, Zhang M, Shames B, Roza A, Cronin D, Hariharan S, Schiller J, Ellis T. Renal Transplantation with Final Allocation Based on the Virtual Crossmatch: Outcomes at 5 Years [abstract]. Am J Transplant. 2013; 13 (suppl 5). https://atcmeetingabstracts.com/abstract/renal-transplantation-with-final-allocation-based-on-the-virtual-crossmatch-outcomes-at-5-years/. Accessed April 22, 2021.

« Back to 2013 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.